Close

Anti-MAP2K1 DNA-encoded mAb (DMAb), pVAX1 (DMAb-3723-FY)


All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

This product is the plasmid containing an encoded anti-MAP2K1 DMAb sequence. The plasmid can drive transcription and in vivo translation of the desired antibody.

  Add to Cart

Specifications

  • Target
  • MAP2K1
  • Vector Name
  • pVAX1
  • Vector Description
  • pVAX1 was originally designed for the development of DNA vaccines. Its eukaryotic DNA sequences limited to the expression of desired sequence so that minimize the possibility of chromosomal integration. This vector has been widely used for the construction of DMAb plasmid.
  • Vector Promoter
  • CMV
  • Vector Tag or Fusion
  • Untagged
  • Delivery Method
  • Transfection
  • Cloning Method
  • Restriction Enzyme ⁄ MCS
  • Constitutive or Inducible System
  • Constitutive
  • Storage
  • Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term.
  • Background
  • DNA-encoded mAb (DMAb) technology is a novel approach for a direct in vivo production of desired biologically active immunoglobulins according to the plasmid DNA delivery into tissue where the delivered plasmid containing an encoded antibody sequence. Compared with the traditional mAb, DMAb can be functionally equivalent with additional advantages such as expression profiles, glycosylation, as well as no reliance on in vivo tissue culture and costly or time-consuming production systems. The DMAb technology may provide a novel, simple, less frequent, cost-effective approach for therapeutics.

Target

  • Entrez Gene ID
  • 5604
Sub CAT. DMAb Clone DMAb Host Target Species DMAb Isotype DMAb Immunogen  
DMAb-3723-FY 25/MEK1 Mouse Human IgG2a Human MEK1 Recombinant Protein
DMAb-3724-FY CBFYM-0006 Human Human IgG1
DMAb-3725-FY CBFYM-0053 Mouse Human IgG1, k Synthetic peptide corresponding to amino acid residues near the C-terminus conjugated to KLH
DMAb-3726-FY CBFYM-0185 Mouse Human IgG2a
DMAb-3727-FY CBFYM-0269 Rabbit Human IgG
DMAb-3728-FY CBFYM-0333 Mouse Human IgG1, k Phosphorylated Human MEK1 Peptide
DMAb-3729-FY CBFYM-0552 Rabbit Human IgG
DMAb-3730-FY CBFYM-0553 Mouse Mouse IgG1
DMAb-3731-FY CBFYM-1414 Mouse Human IgG2a Synthetic peptide corresponding to a portion of MKK1/2 (MAP kinase kinase 1/2)
DMAb-3732-FY CBFYM-1415 Mouse Human IgG1, k MEK1 antibody was raised in Mouse using a recombinant human protein purified from E.coli(His-MEK1)
DMAb-3733-FY CBFYM-1416 Mouse Human IgG2b Protein expressed in 293T cell transfected with human MAP2K1 expression vector
DMAb-3734-FY CBFYM-1417 Mouse Human Mitogen Activated Protein Kinase Kinase 1
DMAb-3735-FY CBFYM-1418 Human Human Full length recombinant human MEK 1 expressed in Sf9 cells
DMAb-3736-FY CBFYM-1419 Mouse Human IgG1 Native MEK and recombinant MEK1
DMAb-3737-FY CBFYM-1420 Mouse Human IgG1, k Recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.Immunogen sequence: GRPLSSYGMD SRPPMAIFEL LDYIVNEPPP KLPSGVFSLE FQDFVNKCLI KNPAERADLK QLMVHAFIKR SDAEEVDFAG WLCSTIGLNQ PSTPTHAAGV
DMAb-3738-FY CBFYM-1421 Rabbit Human IgG
DMAb-3739-FY CBFYM-1422 Mouse Human IgG1 Full length human recombinant protein of human MAP2K1(NP_002746) produced in HEK293T cell
DMAb-3740-FY CBFYM-1423 Mouse Human IgG2a Full length human recombinant protein of human MAP2K1(NP_002746) produced in HEK293T cell
DMAb-3741-FY CBFYM-1424 Rabbit Human IgG Synthetic peptide (KLH coupled) corresponding to human MEK1
DMAb-3742-FY CBFYM-1425 Mouse Human IgG Protein expressed in 293T cell transfected with human MAP2K1 expression vector
DMAb-3743-FY CBFYM-1426 Mouse Human IgG2a Full length MEK1 proteins
DMAb-3744-FY CBFYM-1427 Mouse Human IgG2a E. coli-derived recombinant human MEK1, Lys2-Val393 (Ser218Asp, Ser222Asp)
DMAb-3745-FY CBFYM-1428 Mouse Human IgG1, k Recombinant protein between 1-393 amino acids from human MP2K1
DMAb-3746-FY CBFYM-1429 Rabbit Human IgG Recognizes MEK1
DMAb-3747-FY CBFYM-1430 Rabbit Human IgG Recombinant peptide corresponding to amino acids surrounding the TEY motif in the activation loop of human phospho-MEK1
DMAb-3748-FY CBFYM-1431 Mouse Human IgG1, k A mouse immunized with a recombinant protein between 1-393 amino acids from human MP2K1
DMAb-3749-FY CBFYM-1432 Mouse Human IgG2a
DMAb-3750-FY CBFYM-1433 Mouse Human IgG1
DMAb-3751-FY CBFYM-1434 Rabbit Human
DMAb-3752-FY CBFYM-1435 Mouse Human IgG2a Recombinant Xenopus MEK1
DMAb-3753-FY CBFYM-1436 Mouse Human IgG1
DMAb-3754-FY CBFYM-1437 Mouse Human

Customer Reviews and Q&As

There are currently no customer reviews or questions for Anti-MAP2K1 DNA-encoded mAb (DMAb), pVAX1 (DMAb-3723-FY). Click the button below to contact us or submit your feedback about this product.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Related Products

Online Inquiry

For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.